NL194961B - Composition comprising a component capable of reacting with Pseudomonas aeruginosa flagella, pharmaceutical preparation, cell line, monoclonal antibody, method for determining Pseudomonas aeruginosa, and package for detecting thereof. - Google Patents

Composition comprising a component capable of reacting with Pseudomonas aeruginosa flagella, pharmaceutical preparation, cell line, monoclonal antibody, method for determining Pseudomonas aeruginosa, and package for detecting thereof.

Info

Publication number
NL194961B
NL194961B NL8701554A NL8701554A NL194961B NL 194961 B NL194961 B NL 194961B NL 8701554 A NL8701554 A NL 8701554A NL 8701554 A NL8701554 A NL 8701554A NL 194961 B NL194961 B NL 194961B
Authority
NL
Netherlands
Prior art keywords
pseudomonas aeruginosa
reacting
package
detecting
determining
Prior art date
Application number
NL8701554A
Other languages
Dutch (nl)
Other versions
NL8701554A (en
NL194961C (en
Original Assignee
Genetic Systems Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/946,554 external-priority patent/US4834976A/en
Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp
Publication of NL8701554A publication Critical patent/NL8701554A/en
Publication of NL194961B publication Critical patent/NL194961B/en
Application granted granted Critical
Publication of NL194961C publication Critical patent/NL194961C/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1214—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NL8701554A 1986-07-03 1987-07-02 Composition comprising a component capable of reacting with Pseudomonas aeruginosa flagella, pharmaceutical preparation, cell line, monoclonal antibody, method for determining Pseudomonas aeruginosa, and package for detecting thereof. NL194961C (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US88198486A 1986-07-03 1986-07-03
US88198486 1986-07-03
US94655486 1986-12-24
US06/946,554 US4834976A (en) 1986-07-03 1986-12-24 Monoclonal antibodies to pseudomonas aeruginosa flagella
US4814387A 1987-05-15 1987-05-15
US4814387 1987-05-15

Publications (3)

Publication Number Publication Date
NL8701554A NL8701554A (en) 1988-02-01
NL194961B true NL194961B (en) 2003-05-01
NL194961C NL194961C (en) 2003-09-02

Family

ID=27367280

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8701554A NL194961C (en) 1986-07-03 1987-07-02 Composition comprising a component capable of reacting with Pseudomonas aeruginosa flagella, pharmaceutical preparation, cell line, monoclonal antibody, method for determining Pseudomonas aeruginosa, and package for detecting thereof.

Country Status (19)

Country Link
JP (1) JP2639422B2 (en)
KR (1) KR910002373B1 (en)
AT (1) AT399885B (en)
AU (1) AU615162B2 (en)
BE (1) BE1000743A3 (en)
CH (1) CH677796A5 (en)
DE (1) DE3722098C2 (en)
DK (1) DK172840B1 (en)
ES (1) ES2013321A6 (en)
FR (1) FR2601458B1 (en)
GB (1) GB2192185B (en)
IE (1) IE60888B1 (en)
IL (1) IL83047A (en)
IT (1) IT1221940B (en)
LU (1) LU86938A1 (en)
NL (1) NL194961C (en)
OA (1) OA08629A (en)
PT (1) PT85247B (en)
SE (1) SE506421C2 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772464A (en) * 1985-08-01 1988-09-20 Miles Laboratories, Inc. Protective antibodies to serotypic determinants of flagellar antigens
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella
CA1341375C (en) * 1988-10-12 2002-07-09 Baxter International Inc. Compositions and methods for the treatment and prevention of gram-negative bacterial infections
JPH02299594A (en) * 1989-01-30 1990-12-11 Sumitomo Chem Co Ltd Human monoclonal antibody and production thereof
WO1990013033A1 (en) * 1989-04-14 1990-11-01 Biocontrol Systems, Incorporated Process and device for detecting a particular motile organism
SG50585A1 (en) * 1990-01-18 1998-07-20 Cura Nominees Pty Ltd Glycoalkaloids
US20100272736A1 (en) * 2009-02-04 2010-10-28 Kalobios Pharmaceuticals, Inc. Combination antibiotic and antibody therapy for the treatment of pseudomonas aeruginosa infection
EP2542577A1 (en) * 2010-03-01 2013-01-09 Lostam Biopharmaceuticals Ltd Improved therapeutic antibodies against flagellated pseudomonas aeruginosa

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8422649D0 (en) * 1984-09-07 1984-10-10 Technology Licence Co Ltd Monoclonal antibodies
JP2691708B2 (en) * 1984-09-26 1997-12-17 住友製薬株式会社 Human monoclonal antibody and method for producing the same
HU205630B (en) * 1985-06-06 1992-05-28 Genetic Systems Corp Process for producing monoclonal antibodys inhibiting exotoxine and toxic effect of pseudomonas aeruginosa and specific for them, celle lines producing them and pharmaceutical compositions
DE3689713T2 (en) * 1985-08-01 1994-07-07 Miles Inc Protective antibodies against serotypic determinants of flagellar antigens.
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
ZA868673B (en) * 1985-12-10 1988-07-27 Genetic Systems Corp Monoclonal antibodies cross-reactive and cross-protective against p.aeruginosa serotypes
GB2192185B (en) * 1986-07-03 1991-01-16 Genetic Systems Corp Monoclonal antibodies to pseudomonas aeruginosa flagella

Also Published As

Publication number Publication date
PT85247B (en) 1990-06-29
SE506421C2 (en) 1997-12-15
KR910002373B1 (en) 1991-04-20
DK336687D0 (en) 1987-06-30
AU615162B2 (en) 1991-09-26
GB8715347D0 (en) 1987-08-05
DK172840B1 (en) 1999-08-09
OA08629A (en) 1988-11-30
CH677796A5 (en) 1991-06-28
IL83047A0 (en) 1987-12-31
JP2639422B2 (en) 1997-08-13
LU86938A1 (en) 1988-02-02
GB2192185B (en) 1991-01-16
DE3722098A1 (en) 1988-03-03
NL8701554A (en) 1988-02-01
AU7495887A (en) 1988-01-07
KR880001815A (en) 1988-04-27
SE8702734D0 (en) 1987-07-02
PT85247A (en) 1987-08-01
FR2601458A1 (en) 1988-01-15
IT8721163A0 (en) 1987-07-02
IT1221940B (en) 1990-08-31
DK336687A (en) 1988-01-04
DE3722098C2 (en) 1998-06-04
IE871769L (en) 1988-01-03
IE60888B1 (en) 1994-08-24
IL83047A (en) 1992-12-01
BE1000743A3 (en) 1989-03-28
AT399885B (en) 1995-08-25
SE8702734L (en) 1988-01-04
NL194961C (en) 2003-09-02
ES2013321A6 (en) 1990-05-01
GB2192185A (en) 1988-01-06
FR2601458B1 (en) 1992-08-21
JPS63102697A (en) 1988-05-07
ATA168387A (en) 1994-12-15

Similar Documents

Publication Publication Date Title
IL88248A (en) Solid phase immunoassay for detecting hiv antigens using kc-57 monoclonal antibody, and kit for the performance thereof
KR900702007A (en) Monoclonal antibody that reacts with the T cell antigen receptor site
IL105541A0 (en) Monoclonal antibodies to gp130 protein,processes for the preparation thereof and pharmaceutical compositions containing the same
ZA882998B (en) Simultaneous enzyme immunoassay for detecting antigen and/or antibody in humans
WO1996029605A3 (en) Compounds and methods for the dectection of t. cruzi infection
NL194832B (en) Method for forming a thin semiconductor film.
AU529210B3 (en) Monoclonal antibody in occult blood diagnosis
ZA899875B (en) Immunodiagnostic assays for use in the detection and determination of mastitis
NL194961B (en) Composition comprising a component capable of reacting with Pseudomonas aeruginosa flagella, pharmaceutical preparation, cell line, monoclonal antibody, method for determining Pseudomonas aeruginosa, and package for detecting thereof.
WO1991004059A3 (en) Method and useful apparatus for preparing pharmaceutical compositions
NL181461C (en) METHOD AND REAGENT KIT FOR DETERMINING ANTIGENS, ANTIBODIES OR ANTIGEN-ANTIBODY COMPLEXES OR CONJUGATES.
IT8820741A0 (en) MONOCLONAL ANTIBODY SPECIFIC FOR A SEQUENCE OF FIBRONECTIN EXPRESSED IN TRANSFORMED HYBRIDOMA CELLS SECRETING THIS ANTIBODY AND USE OF THE MONOCLONAL ANTIBODY FOR THE DIAGNOSIS OF TUMORS.
DK556689D0 (en) ANTIBODY CONJUGATES, PROCEDURES FOR PREPARING THEM AND PHARMACEUTICAL AGENTS CONTAINING THESE
DE3682250D1 (en) A MONOCLONAL ANTIBODY AGAINST COPPER-ZINC SUPEROXIDE DISMUTASE, A MEDICINAL PRODUCT FOR DIAGNOSTIC TEST AND THE DIAGNOSTIC TEST METHOD USING THE SAME.
DK392387A (en) MONOCLONAL ANTIBODY FOR DIAGNOSTIC USE AND PROCEDURE FOR MANUFACTURING SUCH ANTIBODY
EP0341303A4 (en) Monoclonal antibody against the rgd-directed adhesion receptor of endothelial cells.
NL167519B (en) METHOD FOR DETERMINING ACCORDING TO A RADIO-IMMUNO TEST OF THE PRESENCE OF NEISSERIA-GONORRHOEAE ANTIBODIES IN HUMAN SERUM.
AU7068587A (en) Monoclonal antibody immunoblot assay for antigens
EP0171083A3 (en) Monoclonal antibody, process for preparing same, reagent for detecting cancer antigen containing the monoclonal antibody and process for preparing same
EP0453097A3 (en) Zusammensetzung enthaltend zumindest zwei verschiedene Antikörper oder deren Fragmente
IL77990A (en) Monoclonal anti-alpha-amylase antibody,process for obtaining the same and pharmaceutical compositions containing the same
FR2363793A1 (en) NEW METHOD FOR THE ASSESSMENT OF ANTIGENS AND ANTIBODIES, ACCORDING TO IMMUNOLOGICAL TECHNIQUE WITH FIXED ENZYME
DE3851855T2 (en) Monoclonal antibody directed against the gamma chain of the T cell receptor.
NO873154L (en) SPECIFIC MONOCLONAL ANTIBODIES AGAINST SURFACE RECEPTOR FOR IGE AND HYBRID CELL LINE PRODUCING THESE ANTIBODIES AND USE THEREOF.
EP0250119A3 (en) Atherosclerotic anti-idiotype antibody immunoassay and reagents

Legal Events

Date Code Title Description
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
V4 Discontinued because of reaching the maximum lifetime of a patent

Effective date: 20070702